Answer
Yes, Baraclude (entecavir) is indicated for chronic hepatitis B in adults with decompensated liver disease, based on clinical trial data in nucleoside-naive patients with HBeAg-positive or HBeAg-negative HBV infection.
Sources for this answer
- Baraclude 0.05 mg/ml oral solutionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.1 Therapeutic Indications · Version 6Document updated
Sources checked